Guardion Health Sciences Inc Receivables Turnover Ratio (GHSI), from the second quarter 2024 to the second quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Guardion Health Sciences Inc   (NASDAQ: GHSI)
 

Guardion Health Sciences Inc Accounts Receivables Turnover Ratio from the second quarter 2024 to the second quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Guardion Health Sciences Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2024 to a ratio of 7.86, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Guardion Health Sciences Inc in Jun 30 2024 quarter, has decreased to 46 days, compared to 50 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 195 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1807, from overall ranking in the first quarter 2024 at 2281.

What is Receivable Turnover Ratio?
What is Guardion Health Sciences Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GHSI Receivables Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Receivable Change -99.18 % 8.04 % -99.52 % -5.75 % -22.34 %
Y / Y Revenue Change -96.76 % -6.69 % 7.68 % 17.82 % -6.26 %
Receivable Turnover Ratio (TTM) 7.86 7.23 7.57 5.43 5.15
GHSI's Total Ranking # 1807 # 2281 # 1793 # 1756 # 984
Accounts Receivable average collection period days 46 50 48 67 71
Seq. Receivable Change -99.39 % 22516.4 % -99.47 % 13.56 % -20.12 %
Seq. Revenue Change -96.65 % -25.78 % 19.33 % 9.38 % -3.68 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 196
Overall Market # 1807

Receivable Turnover Ratio Statistics
High Average Low
76.08 20.45 3.85
(Dec 31 2020)   (Jun 30 2021)





GHSI Company Profile • Back to GHSI Efficiency Comparisons • Compare GHSI Receivables Turnover Ratio to its Competitors

Financial Statements
Guardion Health Sciences Inc 's Accounts Receivable $ 0 Millions Visit GHSI's Balance sheet
Guardion Health Sciences Inc 's Sales TTM $ 8 Millions Visit GHSI's Income Statement
Sources of GHSI's Revenues Visit GHSI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GHSI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GHSI's Growth Rates GHSI's Roa GHSI's Inventory Turnover Ratio GHSI's Dividend Comparisons
GHSI's Profitability Ratios GHSI's Roi GHSI's Asset Turnover Ratio GHSI's Dividend Growth
GHSI's Valuation Ratios GHSI's Roe GHSI's Financial Strength Ratios GHSI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Receivable at quarter ending Jun 30 2024
Provectus Biopharmaceuticals Inc   1,195.64 $ 0.684  Millions$ 0.001  Millions
Bicycle Therapeutics Plc  679.38 $ 39.574  Millions$ 0.058  Millions
Warby Parker Inc   589.39 $ 718.462  Millions$ 1.219  Millions
Keros Therapeutics Inc   281.07 $ 26.210  Millions$ 0.093  Millions
Bausch Health Companies Inc   272.65 $ 9,202.000  Millions$ 33.750  Millions
Electromedical Technologies Inc   224.48 $ 1.203  Millions$ 0.005  Millions
Waters Corporation  182.79 $ 2,876.534  Millions$ 15.737  Millions
Zeo Scientifix Inc   166.27 $ 4.798  Millions$ 0.029  Millions
Roivant Sciences Ltd   158.70 $ 158.303  Millions$ 0.998  Millions
Logicmark Inc  131.04 $ 9.740  Millions$ 0.074  Millions
Earth Science Tech Inc   129.16 $ 19.889  Millions$ 0.154  Millions
Nurix Therapeutics Inc   124.61 $ 62.303  Millions$ 0.500  Millions
Healthlynked Corp  120.74 $ 4.063  Millions$ 0.034  Millions

Date modified: 2026-10-07T00:41:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.